Status:
COMPLETED
A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
Lead Sponsor:
UCB Japan Co. Ltd.
Conditions:
Epilepsies
Partial
Eligibility:
All Genders
16-65 years
Phase:
PHASE3
Brief Summary
This study is planned to evaluate the safety and efficacy of L059 (levetiracetam) in long-term administration in patients who completed N01020 \[NCT00160165\] or N01221 \[NCT00280696\].
Eligibility Criteria
Inclusion
- Patients who participated in study N01221 \[NCT00280696\] and completed the evaluation period and transition period or patients who participated in study N01020 \[NCT00160615\]
Exclusion
- Female patients during pregnancy, delivery and lactation, or suspected of pregnancy
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
398 Patients enrolled
Trial Details
Trial ID
NCT00367432
Start Date
July 1 2006
End Date
December 1 2010
Last Update
November 13 2020
Active Locations (53)
Enter a location and click search to find clinical trials sorted by distance.
1
Aichi-gun, Aichi-ken, Japan
2
Nagoya, Aichi-ken, Japan
3
Hirosaki, Aomori, Japan
4
Matsudo, Chiba, Japan